GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Coegin Pharma (NGM:COEGIN) » Definitions » Float Percentage Of Total Shares Outstanding

Coegin Pharma (NGM:COEGIN) Float Percentage Of Total Shares Outstanding : 0.00% (As of May. 19, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Coegin Pharma Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Coegin Pharma's float shares is 0.00 Mil. Coegin Pharma's total shares outstanding is 20.34 Mil. Coegin Pharma's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Coegin Pharma's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Coegin Pharma's Institutional Ownership is 0.00%.


Coegin Pharma Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Coegin Pharma's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/20.34
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Coegin Pharma (NGM:COEGIN) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Coegin Pharma (NGM:COEGIN) » Definitions » Float Percentage Of Total Shares Outstanding
Traded in Other Exchanges
N/A
Address
Birger Jarlsgatan 18 A, 4th Floor, Stockholm, SWE, 114 34
Coegin Pharma AB is a biotechnology company that focuses on the development of small molecule therapies for the treatment of inflammatory diseases such as cancer and kidney disease.

Coegin Pharma (NGM:COEGIN) Headlines

No Headlines